PMV Pharmaceuticals, Inc. (PMVP): Operating Cash Flow
-$73.58M
Year ended 2025-12-31
-$71.27M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$73.58M | n/m | 2026-03-06, From 2025-01-01 |
| 2024-12-31 | -$51.28M | n/m | 2026-03-06, From 2024-01-01 |
| 2023-12-31 | -$55.66M | n/m | 2026-03-06, From 2023-01-01 |
| 2022-12-31 | -$63.76M | n/m | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | -$46.57M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$32.74M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$22.07M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$15.18M | n/a | 2021-03-03, From 2018-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | -$73.58M | n/m |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | -$45.65M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$51.46M | n/m |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | -$54.17M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$29.55M | n/m |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | -$32.25M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$18.92M | n/m |
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | -$4.77M | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | -$49.04M | n/m |
Compare PMVP, SGMT, AVTX, AARD side by side · Screen every company in Pharmaceutical Preparations ↗